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Platelet endothelial cell adhesion molecule-1 (PECAM-1) (CD31) is sine-based inhibitory motif subfamily of the Ig superfamily
an adhesion molecule believed to mediate transendothelial migra- (3). Many studies have demonstrated that it plays a critical
tion of neutrophils and other leukocytes after CD11/CD18-medi- role in the transendothelial migration of neutrophils (10). In
ated adhesion. Our study evaluated the role of PECAM-1 in neutro- vitro studies show that anti–PECAM-1 antibody or soluble
phil emigration across the pulmonary capillaries and the bronchial PECAM-1 inhibits neutrophil transmigration across the en-
microvasculature using blocking anti–PECAM-1 antibodies in mice dothelium activated by tumor necrosis factor (TNF)- (11).
and rats. Neutrophil emigration was induced by Escherichia coli, a Similarly, in vivo studies show that anti–PECAM-1 antibody
stimulus eliciting CD11/CD18-dependent emigration, or Strepto- blocks neutrophil emigration in chemical-induced peritonitis
coccus pneumoniae, a stimulus inducing CD11/CD18-independent (12–14).
emigration. Although anti–PECAM-1 antibodies partially inhibited PECAM-1 is expressed constitutively on pulmonary arte-
glycogen-induced neutrophil emigration into the peritoneum, neu- rial, capillary, and venular endothelium, yet many questions
trophil emigration across either the pulmonary capillaries or the
regarding the role that this highly expressed cell adhesionbronchial microvasculature in response to either E. coli or S. pneu-
molecule plays in pulmonary inflammation remain. An in-moniae was not prevented when the function of PECAM-1 was
crease in PECAM-1 expression has been reported in miceinhibited in either mice or rats. There was also no increase in the
exposed to 100% oxygen for 3 to 4 days, although the func-number of intravascular neutrophils within the bronchial vessels
tional significance of this change was not studied (15). Theafter treatment with anti–PECAM-1 antibody. These studies indicate
only functional studies, to our knowledge, have been by Va-that either CD11/CD18-dependent or -independent adhesion path-
porciyan and colleagues who showed that IgG immune com-ways may lead to PECAM-1–independent transendothelial migra-
plex-induced lung injury, a process requiring neutrophils,tion through the pulmonary or the bronchial endothelium.
interleukin (IL)-1, TNF-, CD11/CD18, intercellular adhe-
Keywords: rodent; lung; neutrophils; infectious immunity-bacteria; ad- sion molecule-1, and E-selectin, also required PECAM-1 for
hesion molecules neutrophil emigration into the alveolar space (12, 16–19).
The role of PECAM-1 in bacterial pneumonia has notNeutrophil emigration into the alveolar space is one of the been evaluated. In contrast to the microcirculation of manyhallmarks of acute bacterial pneumonia (1). During bacterial organs, neutrophil emigration through the pulmonary capil-pneumonia, neutrophils marginate within the microvascula- lary bed into the distal airspaces of the lung during the acuteture, adhere to endothelial cells, and transmigrate between inflammatory response can occur through adhesion pathwaysendothelial cells into the alveolar space. Each step in this that do not require CD11/CD18 (20–22). The purpose ofprocess is mediated by specific mechanisms and molecules. these studies was to examine the role of PECAM-1 in eitherPlatelet endothelial cell adhesion molecule-1 (PECAM-1) Escherichia coli–induced pneumonia, where neutrophil emi-(CD31) is a transmembrane protein and a member of immu- gration occurs through CD18-dependent adhesion pathwaysnoglobulin (Ig) gene superfamily structurally related to inter- (22, 23), or Streptococcus pneumoniae–induced pneumonia,cellular adhesion molecule-1 (2, 3). It is constitutively ex- a stimulus eliciting CD18-independent emigration (20, 22).pressed at the junctions between endothelial cells and on the In addition, the function of PECAM-1 in the pulmonarysurface of leukocytes and platelets (2–5). Roles for PECAM-1 and bronchial circulations was compared in the response ofin modulating leukocyte adhesion and migration, angiogen- neutrophils with either stimulus.esis, and thrombosis have been described (5–9). PECAM-1
is also an intracellular signaling molecule, and recent studies
METHODShave suggested it is a member of the immunoreceptor tyro-
Antibodies
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mice (14). For studies measuring PECAM-1 protein expression in im- the trachea into a small bronchus, and 250 l of the suspension of E.
coli and S. pneumoniae mixed with 5% colloidal carbon was instilled.munoblots, the polyclonal goat anti-mouse PECAM-1 antibody M-
Blood samples were drawn from the carotid artery at 3 and 6 hours after20 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) was used. This
instillation. After 6 hours, saturated potassium chloride was injectedantibody was raised against a peptide from the carboxy terminal region
through the carotid catheter to stop the heart. The chest was openedof murine PECAM-1.
immediately, and the heart was tied at the base to prevent loss of blood
from the lungs. The lungs were removed en bloc from the chest cavityExpression of PECAM-1 in E. coli- and
and fixed using 6% glutaraldehyde in phosphate-buffered saline atS. pneumoniae–induced Pneumonia
25 cm H2O.To localize the expression of PECAM-1, Lewis rats (250–300 g; Harlan Quantitation of neutrophil emigration. Lung tissue was cut from the
Sprague Dawley, Inc., Indianapolis, IN) and C57 BL/6 mice (18–26 g; blacked, colloidal carbon-containing regions, embedded in paraffin, and
Jackson Laboratories, Bar Harbor, ME) were given either no stimulus sectioned at 5 to 6 m. The accumulation of neutrophils into the alveolar
or an intratracheal instillation of E. coli or S. pneumoniae for 6 hours spaces was quantitated on hematoxylin and eosin-stained histologic
as described below. Optimum cutting temperature compound (Tissue- sections using two methods:
Tek) diluted 1:1 with normal saline was instilled through the trachea,
Method 1: in E. coli pneumonia, the number of neutrophils that mi-and the lungs were frozen in liquid nitrogen. Rat hearts were also
grated into colloidal carbon-containing alveolar spaces was counted.removed and frozen. Histologic frozen sections (7–9 m) were cut.
Neutrophil emigration was calculated as the number of neutrophilsImmunohistochemistry was performed by incubating the frozen sections
per 100 alveoli (20).after fixation in acetone with the appropriate anti–PECAM-1 antibody
Method 2: in E. coli and S. pneumoniae pneumonias, point-counting(0.02 mg/ml) followed by a biotin-labeled rat anti-rabbit or goat anti-
techniques were used to calculate the percent of the distal lung paren-rat IgG secondary antibody (Kirkegaard and Perry Laboratories, Inc.,
chyma that was occupied by intra-alveolar neutrophils. Five hundredGaitherburg, MD). After incubation with streptavidin–alkaline phos-
points were observed for each slide (26, 27). Each point was classifiedphatase conjugates (Kirkegaard and Perry Laboratories, Inc.), the tissue
as falling on a neutrophil within the alveolar space or the space itself.sections were incubated with a substrate containing new fushcin, a red
The percentage of alveolar neutrophils was calculated as: number ofdye, to localize the antigen. In the negative control sections, the primary points on alveolar neutrophils/number of points on alveolar space.
antibody was replaced by either nonspecific rabbit or rat IgG or Tris
Neutrophil emigration from the bronchial (systemic) circulation wasbuffer. Anti-rat CD18 antibody was used as a positive control.
evaluated by quantitating the number of neutrophils that migrated intoTo quantitate PECAM-1 expression, protein was extracted from
the bronchial wall (26). In each animal, two to three large bronchihomogenates of noninfected lungs and lungs with either S. pneumoniae
within the region of pneumonia were studied. The bronchial wall areaor E. coli pneumonia (n  5 in each group). Immunoblots were per-
was measured by digitizing the outer perimeter of the adventitia, theformed by electrophoresis using 20 g protein per lane, and the blots
inner bronchial epithelial length, and the endothelial length of bronchialwere stained with the polyclonal anti-murine PECAM-1 antibody M-20,
blood vessels within the bronchial wall and was calculated as: bronchialwhich recognizes all PECAM-1 isoforms. PECAM-1 staining (MW
wall area  total area  airway luminal area  blood vessel luminal120,000–130,000) was measured using densitometry and expressed as a
area. The number of neutrophils that migrated into the bronchial wallfold change relative to that observed in noninfected lungs.
was counted and expressed as the number of neutrophils/1,000 m2
bronchial wall. The number of neutrophils sequestered within the bron-Neutrophil Emigration in Glycogen-induced Peritonitis in Rats
chial vessels was also counted and expressed as neutrophils/1,000 m2
Anesthetized rats (n  4 in each group) received an intravenous injec- bronchial vessel lumen.
tion of anti–PECAM-1 antibody (200 g/rat) or rabbit IgG. After 15
minutes, oyster glycogen (25 ml of 0.1% solution) was instilled into the Neutrophil Emigration and Edema Formation during Bacterial
peritoneal space. Control rats received no glycogen. After 4 hours, the Pneumonia in Mice
peritoneal space was lavaged with three aliquots of 50 ml phosphate-
To determine the role of PECAM-1 in bacterial pneumonia in mice,buffered saline. The leukocyte count in the peritoneal lavage fluid
anesthetized C57BL/6 mice were given an intravenous injection of ei-was quantitated using a hemocytometer, and neutrophil counts were
ther a blocking anti–PECAM-1 mAb (Mec 13.3; 200 g/mouse) or adetermined using Wright-stained cytospin preparations. A blood sam- nonblocking anti–PECAM-1 mAb (390; 200 g/mouse) 15 minutes
ple was collected in heparin from the inferior vena cava to determine before the intratracheal instillation of either S. pneumoniae (5.9  108
the circulating leukocyte counts. CFU/ml) or E. coli (1.1  108 CFU/ml) suspension (50 l/22 g of body
weight) mixed with 5% colloidal carbon as a tracer (n  5 in each
Neutrophil Emigration in E. coli- and S. pneumoniae–induced group [14, 24, 27–30]). Uninfected mice received no instillate (n  5).
Pneumonia in Rats Neutrophil emigration was quantitated morphometrically in histologic
sections by quantitating the fraction of distal lung tissue that was occu-Induction of pneumonia. To examine neutrophil emigration into bron-
pied by intra-alveolar (emigrated) neutrophils using point-countingchi supplied by the bronchial circulation, as well as into the alveolar
techniques, as described previously (26, 27, 29, 30). Edema formationspace through the pulmonary capillaries, both suspended single organ-
was measured by determining the accumulation of extravascular 125I-isms and agar-embedded organisms were instilled into the airways. E.
labeled albumin 6 hours after instillation of organisms using 51Cr-labeledcoli and S. pneumoniae were grown on trypticase soy agar plates over-
murine red blood cells to mark intravascular blood volumes and wasnight. The surface of agar was scraped and the organisms and fragments
expressed as microliters plasma equivalents/gram body weight, as de-of agar were suspended in saline. The bacterial suspensions were diluted
scribed previously (29, 30).to 1.0 absorbance U/ml at 600 nm (2.5  109 E. coli/ml and 3.9  109
S. pneumoniae/ml). One control and one anti–PECAM-1 antibody- Statistical Analysis
treated rat were studied using the same suspension to control for any
One-way analyses of variance were used to compare neutrophil accumu-day-to-day variability in the concentration of organisms.
lation between the groups (31). If this analysis showed any significantThe rats were anesthetized using ketamine hydrochloride (80–100
differences, multiple contrasts were used with a Bonferroni adjustmentmg/kg intramuscularly) and acepromazine maleate (8–10 mg/kg). Addi-
to determine which groups were significantly different (32). A p valuetional anesthesia was given as required throughout the experiment. A
less than 0.05 was considered to be statistically significant.ventral incision was made in the neck, and the left carotid artery and
trachea were isolated. The carotid artery was cannulated using a 14-
RESULTSgauge catheter for drawing blood samples. A tracheotomy was per-
formed. After a blood sample was obtained for measurement of circulat- Expression of PECAM-1 in E. coli–induced and
ing leukocyte counts and differentials, the rats (n  4 in each group) S. pneumoniae–induced Pneumonia in Rats and Micereceived either anti–PECAM-1 antibody or rabbit IgG (200 g/per rat,
Immunohistochemical studies showed that the polyclonal rabbitn  4 in each group) through a tail vein. After 15 minutes, a blood
sample was drawn, a neonatal feeding tube (3.5 Fr) was passed through anti-human PECAM-1 antibody bound to rat cardiac arteriolar
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Figure 1. PECAM-1 protein ex-
pression in protein isolates
from homogenates of nonin-
fected murine lungs or lungs
with E. coli or S. pneumoniae
pneumonia. (A ) Immunoblot
comparing five lungs in each
group. Each lane represents 20
g protein from the lungs of
one mouse. (B ) Relative inten-
sity of PECAM-1 expression ex-
pressed as a fold change from
noninfected lungs; n  5 mice
in each group.
and venular endothelial cells. This antibody also recognized the Neutrophil Emigration in E. coli- or S. pneumoniae–induced
endothelium lining the arterioles, venules, and alveolar capillar- Pneumonia in Rats
ies in the lungs of uninfected rats, as reported previously (12). The role of PECAM-1 in neutrophil emigration into the alveolar
Using this technique, no change in the expression of PECAM-1 space of rats was evaluated using two morphometric techniques.
after instillation of either E. coli or S. pneumoniae could be The percentage of the alveolar space that was occupied by neu-
identified. Similarly, using the rat anti-murine PECAM-1 anti- trophils in either S. pneumoniae–induced or E. coli–induced
pneumonia is shown in Figure 2. Pretreatment with anti–PECAM-1body, the murine pulmonary and bronchial microvascular endo-
antibodies did not inhibit neutrophil emigration in pneumoniathelial cells constitutively expressed PECAM-1, and no increase
induced by either stimulus. Using a completely different morpho-in staining over this bright baseline level could be identified
logic approach of counting the number of neutrophils per 100during pneumonia (data not shown).
cross-sectioned alveolar spaces, similar results were observed inPECAM-1 protein expression was quantified in murine lungs
E. coli pneumonia, where neutrophil emigration was similarusing immunoblots (Figure 1). PECAM-1 expression was not
in rats pretreated with anti–PECAM-1 antibody (1,442  48
increased and in fact was decreased slightly by 25 to 30% in neutrophils/100 alveoli) compared with rats pretreated with rab-
both E. coli and S. pneumoniae pneumonia compared with non- bit IgG (1,587  36 neutrophils/100 alveoli, p  0.05).
infected lungs.
Neutrophil Emigration in Glycogen-induced Peritonitis in Rats
To confirm the activity of our anti–PECAM-1 antibody in rats,
its effect on glycogen-induced peritonitis was studied. The num-
ber of neutrophils present within the peritoneal lavage fluid
was measured 4 hours after instillation of glycogen into the
peritoneum. Instillation of glycogen induced neutrophil emigra-
tion into the peritoneal cavity from 0.04  0.02  106/ml to
34.0  2.7  106/ml lavage fluid in rats given rabbit IgG. This
emigration was inhibited by 60% when rats received anti–
PECAM-1 antibody (13.7  4.6  106 neutrophils/ml lavage
Figure 2. Neutrophil emigration in S. pneumoniae or E. coli in rats pre-fluid) compared with those given rabbit IgG (p  0.05). The
treated with either anti–PECAM-1 antibody or rabbit IgG. The percent-
circulating neutrophil count in the anti–PECAM-1 antibody- age of the alveolar space that was occupied by neutrophils in the lungs
treated animals measured 2.2  0.2  106/ml blood and was of rats pretreated with the anti–PECAM-1 antibody (solid bars) was
similar to that in the animals treated with rabbit IgG (2.4  similar to that in rats given the control antibody (open bars) in either
S. pneumoniae or E. coli pneumonias; n  4 rats in each group.0.2  106/ml blood) at 4 hours.
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Figure 3. Neutrophil emigration into the bronchial wall induced by S. Figure 4. Neutrophil accumulation within the bronchial microvascula-
pneumoniae or E. coli or in rats pretreated with anti–PECAM-1 antibody ture in rats with either S. pneumoniae or E. coli pneumonia that were
or rabbit IgG. Both S. pneumoniae and E. coli induced a significant in- pretreated with anti–PECAM-1 antibody or rabbit IgG. The number of
crease in the number of neutrophils that emigrated into the bronchial neutrophils sequestered within the bronchial microvasculature was not
wall. This emigration was not inhibited when the rats were pretreated increased after administration of the anti–PECAM-1 antibody in pneu-
with the anti–PECAM-1 antibody. Open bars: rats pretreated with rabbit monia induced by either organism. Open bars: rats pretreated with rab-
IgG. Solid bars: rats pretreated with anti–PECAM-1 antibody; n  4 rats bit IgG. Solid bars: rats pretreated with anti–PECAM-1 antibody; n  4
in each group. rats in each group.
Both S. pneumoniae and E. coli induced neutrophil emigrationNeutrophil emigration into the bronchial walls is shown in
within 6 hours because the volume fraction of airspaces that wasFigure 3. The accumulation of extravascular neutrophils within
occupied by neutrophils was only 0.02  0.02% and their volumethe bronchial walls induced by either E. coli or S. pneumoniae
fraction of capillaries was 1.8  0.3% in uninfected murine lungs.was not inhibited by anti–PECAM-1 antibody. The number of
The anti–PECAM-1 antibody Mec 13.3 did not inhibit the num-intravascular neutrophils that were within the bronchial vessels
ber of emigrated or intravascular neutrophils for either S. pneu-was not increased after administration of anti–PECAM-1 anti- moniae or E. coli. For S. pneumoniae pneumonia, the number
body (Figure 4). of emigrated neutrophils was in fact significantly greater in the
Injection of anti–PECAM-1 did not cause any change in ei- mice treated with anti–PECAM-1 mAb compared with those
ther the circulating leukocyte or neutrophil counts (Table 1). given control antibody. The physiologic significance of this in-
The neutrophil counts increased within the first 3 hours of the crease is unclear.
experiment in animals with or without instillations of organisms. Pulmonary edema formation was also examined 6 hours after
This increase was similar in IgG-treated compared with anti– intratracheal instillation of bacterial suspension (Figure 6). Both
PECAM-1 antibody-treated rats with either type of pneumonia. S. pneumoniae and E. coli induced an increase in EVA within
6 hours from 0.6  0.1 l/g body weight in uninfected lungs.Effect of Anti–PECAM-1 mAb on Bacterial Pneumonia in Mice There was no significant difference in pulmonary edema between
To extend the observations made in rats to a second species, the mice treated with anti–PECAM-1 mAb and those adminis-
neutrophil emigration into the airspaces of mice was examined tered control antibody after the instillation of either S. pneumo-
6 hours after intratracheal instillation of bacteria in animals niae or E. coli.
Injection of anti–PECAM-1 mAb did not cause any changetreated with anti–PECAM-1 mAb or control antibody (Figure 5).
TABLE 1. CIRCULATING NEUTROPHIL COUNTS IN UNINFECTED RATS AND RATS
WITH PNEUMONIA
Pretreated with Rabbit
Pretreated with Rabbit IgG Anti–PECAM-1 mAb
Time after Instillation (h) (neutrophils  106/ml blood ) (neutrophils  106/ml blood )
Streptococcus pneumoniae pneumonia
0.25 0.6  0.06 0.4  0.07
0 0.6  0.13 0.6  0.12
3 1.7  0.09 2.0  0.33
6 1.1  0.09 1.2  0.24
Escherichia coli pneumonia
0.25 0.8  0.05 0.9  0.31
0 0.7  0.05 0.6  0.12
3 2.6  0.38 2.1  0.41
6 1.2  0.17 0.8  0.05
No organisms
0.25 0.46  0.22
0 0.56  0.08
3 2.1  0.07
6 1.6  0.13
Definition of abbreviations: IgG  immunoglobulin G; mAb  monoclonal antibody; PECAM-1  platelet endothelial cell adhesion
molecule.
There are no significant differences in circulating neutrophil counts between noninfected rats and those with either infection
or between rats treated with anti–PECAM-1 antibodies and those treated with control IgG.
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Figure 5. The percent of the distal lung occupied by either emigrated Figure 6. Edema formation in mice with S. pneumoniae or E. coli pneu-
or intracapillary neutrophils in mice with S. pneumoniae or E. coli pneu- monia and pretreated with either a blocking (Mec 13.3) or nonblocking
monia that were pretreated with either a blocking (Mec 13.3) or non- (390) anti–PECAM-1 antibody. Edema formation was similar in mice
blocking (390) anti–PECAM-1 antibody. The number of neutrophils that treated with the blocking (solid bars) compared with the nonblocking
emigrated was significantly increased in S. pneumoniae pneumonia when antibody (open bars) in pneumonia induced by either organism; n 
the animals were pretreated with the blocking anti–PECAM-1 antibody 5 mice in each group.
(solid bars) compared with a nonblocking antibody (open bars). A similar
trend was observed for E. coli pneumonia, but the differences did not
reach significance. There was no significant difference in the numbers
of intravascular neutrophils in pneumonia induced by either organism. served to accumulate in the lumen of the vessels and within the
n  5 mice in each group. *p Values less than 0.05. vessel wall between the endothelium and the basement mem-
brane (12, 13, 36, 37). These data suggest that, at least in some
types of inflammatory responses, PECAM-1 plays an important
role in the passage of neutrophils across the endothelium and/
in either the circulating leukocyte or neutrophil counts, which or through the basement membrane, a proposal that is consistent
were not different from those of uninfected mice (neutrophil with in vitro studies of cultured endothelial cells (40). This hy-
counts in mice treated with the Mec 13.1 antibody: 1.07  0.01, pothesis is also supported by recent findings from investigations
390 control antibody: 1.04  0.01  106 neutrophils/ml blood in of PECAM-1–deficient mice (41, 42).
S. pneumoniae pneumonia and Mec 13.1 antibody: 1.17  0.02, The lack of a role for PECAM-1 during bacterial pneumonias
390 control antibody: 1.18  0.02  106 neutrophils/ml blood in is unlikely to be due to nonbioactive or ineffective antibody
E. coli pneumonia). reagents. First, the antibodies stained endothelial cells in the
vasculature of the myocardium and in the lung from both species
DISCUSSION of animals (data not shown). Second, the antibodies employed
in this study to inhibit the function of PECAM-1 have beenIn order to investigate the involvement of PECAM-1 in neutro-
previously shown to block chemical peritonitis, as well as inphil emigration during bacterial pneumonia, the effects of anti-
vivo angiogenesis, in mice and rats (8, 9, 12, 14). Third, thebodies against PECAM-1 were studied in both rats and mice
anti–PECAM-1 antibody used in the rat experiments inhibitedgiven an airway instillation of either S. pneumoniae or E. coli.
neutrophil emigration into the distal airways of the lung duringAnti–PECAM-1 antibodies that were capable of blocking neu-
IgG immune complex-induced injury (12). Fourth, the studiestrophil recruitment during glycogen-induced peritonitis or IgG
presented here reconfirmed that the anti-rat PECAM-1 antibodyimmune complex-induced lung injury failed to inhibit neutrophil
blocked neutrophil transendothelial migration after intraperito-emigration out of either the bronchial or the pulmonary micro-
neal injection of glycogen.vasculature. Moreover, no increase in neutrophil concentration
These data support recent observations that suggest that onlywas observed within either the pulmonary capillaries or the bron-
certain types of inflammatory processes use PECAM-1–depen-chial microvasculature, which would occur if transendothelial
dent mechanisms of neutrophil transmigration. Differential re-migration were prevented by PECAM-1 blockade. These data
quirements for PECAM-1 may be due to the differential effectssuggest that neutrophil recruitment in response to a bacterial
of these agents on neutrophil activation. Studies examining cyto-challenge may occur independently of PECAM-1, whether emi-
kine or chemoattractant-induced inflammation in the mesenterygration occurs through S. pneumoniae–elicited CD18-indepen-
or the cremaster muscle show that PECAM-1 blockade is effec-dent or E. coli–elicited CD18-dependent adhesion pathways. These
tive after IL-1	 stimulation but not after exposure of blood vesselsstudies provide further evidence for the presence of multiple
to TNF- or to direct neutrophil activators such as formyl-methi-pathways of neutrophil emigration in the lungs.
onyl-leucyl-phenylalanine (36, 37, 41, 42). Similar results wereThe function of PECAM-1 in neutrophil emigration into tis-
obtained in in vitro transmigration assays where anti–PECAM-1sues other than the lungs has been examined in several in vivo
antibodies block transmigration of IL-1–treated but not IL-8–systems. Antagonism of PECAM-1 function blocks neutrophil
treated transwells, as well as in vivo studies where PECAM-1recruitment during chemical peritonitis (12–14, 33–35), mesen-
blockade prevented neutrophil extravasation after intradermalteric inflammation induced by IL-1	 (36, 37), myocardial isch-
emia-reperfusion injury (33, 38), and cutaneous inflammation injections of TNF but not leukotriene B4 in mice (unpublished
data). In the lungs, the anti–PECAM-1 antibody blocked neutro-(12, 14, 39). In all of these studies, treatment with anti–PECAM-1
antibodies or blocking reagents resulted in diminished leukocyte phil extravasation during IgG immune complex-induced injury
(an IL-1, TNF-, and CD11/CD18-dependent process [12, 16–extravasation. In many of these studies, neutrophils were ob-
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19]), but had no effect, as noted in this report, on neutrophil complexes (12, 16–19), a second requires CD11/CD18 but not
PECAM-1 and includes emigration induced by E. coli, and aemigration triggered by E. coli (a process that is also mediated
by IL-1, TNF-, and CD11/CD18, [22, 30]) or S. pneumoniae. third pathway mediates emigration through CD11/CD18- and
PECAM-1–independent mechanisms, as demonstrated by emi-Coupled with previous reports indicating that PECAM-1 is not
required for neutrophil extravasation triggered in response to gration induced by S. pneumoniae. These pathways may reflect
differences in pattern and nature of the mediators that are gener-formyl-methionylleucylphenylalanine (37, 42), these data sug-
gest that bacterially derived products or mediators may induce ated by the specific inflammatory stimulus.
PECAM-independent emigration that fully compensates for any
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